SKBA Capital Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12M | Buy |
495,550
+47,200
| +11% | +$1.14M | 1.73% | 28 |
|
|
2025
Q1 | $11.4M | Sell |
448,350
-1,900
| -0.4% | -$48.1K | 1.69% | 23 |
|
|
2024
Q4 | $11.9M | Buy |
450,250
+21,400
| +5% | +$568K | 1.89% | 20 |
|
|
2024
Q3 | $12.4M | Buy |
428,850
+17,000
| +4% | +$492K | 1.84% | 20 |
|
|
2024
Q2 | $11.5M | Buy |
411,850
+97,750
| +31% | +$2.74M | 1.85% | 24 |
|
|
2024
Q1 | $8.72M | Buy |
314,100
+19,500
| +7% | +$541K | 1.36% | 39 |
|
|
2023
Q4 | $8.48M | Buy |
+294,600
| New | +$8.48M | 1.43% | 40 |
|
|
2023
Q1 | – | Sell |
-7,000
| Closed | -$359K | – | 78 |
|
|
2022
Q4 | $359K | Hold |
7,000
| – | – | 0.07% | 62 |
|
|
2022
Q3 | $306K | Sell |
7,000
-3,450
| -33% | -$151K | 0.06% | 64 |
|
|
2022
Q2 | $548K | Hold |
10,450
| – | – | 0.11% | 55 |
|
|
2022
Q1 | $541K | Sell |
10,450
-700
| -6% | -$36.2K | 0.1% | 56 |
|
|
2021
Q4 | $658K | Sell |
11,150
-2,100
| -16% | -$124K | 0.12% | 53 |
|
|
2021
Q3 | $570K | Buy |
13,250
+100
| +0.8% | +$4.3K | 0.11% | 57 |
|
|
2021
Q2 | $515K | Buy |
13,150
+2,050
| +18% | +$80.3K | 0.1% | 58 |
|
|
2021
Q1 | $402K | Sell |
11,100
-1,150
| -9% | -$41.6K | 0.06% | 64 |
|
|
2020
Q4 | $451K | Buy |
12,250
+5,399
| +79% | +$199K | 0.08% | 58 |
|
|
2020
Q3 | $239K | Buy |
+6,851
| New | +$239K | 0.05% | 67 |
|
|
2014
Q2 | – | Sell |
-472,347
| Closed | -$14.4M | – | 96 |
|
|
2014
Q1 | $14.4M | Buy |
472,347
+93,911
| +25% | +$2.86M | 1.34% | 38 |
|
|
2013
Q4 | $11M | Sell |
378,436
-8,745
| -2% | -$254K | 1.28% | 38 |
|
|
2013
Q3 | $10.6M | Sell |
387,181
-100,867
| -21% | -$2.75M | 1.28% | 41 |
|
|
2013
Q2 | $13M | Buy |
+488,048
| New | +$13M | 1.53% | 31 |
|